Prospective randomized controlled clinical and histopathological study of acne vulgaris treated with dual mode of quasi-long pulse and Q-switched 1064-nm Nd:YAG laser assisted with a topically applied carbon suspension

Journal of the American Academy of Dermatology

Volumn 66, Issue 4, 2012, Pages 626-633

  Jung, Jae Yoon ^a   Hong, Jong Soo ^a   Ahn, Chang Ho ^a   Yoon, Ji Young ^a   Kwon, Hyuck Hoon ^a   Suh, Dae Hun ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

acne; histopathologic examination; Nd:YAG laser; sebum output

Indexed keywords

CARBON; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ACNE VULGARIS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; DRY SKIN; EPITHELIUM; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOLOGY; INFLAMMATORY CELL; LOW LEVEL LASER THERAPY; MALE; PAIN; PATIENT ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAFETY; SEBUM; SINGLE BLIND PROCEDURE; SKIN EXFOLIATION; STRATUM CORNEUM; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; YAG LASER;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADULT; CARBON; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LASERS, SOLID-STATE; MALE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SUSPENSIONS;

EID: 84858338273     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.08.031     Document Type: Article

References (26)

1. J.J. Leyden Therapy for acne vulgaris N Engl J Med 336 1997 1156 1162
2. G. Goodman Acne - natural history, facts and myths Aust Fam Physician 35 2006 613 616
3. J.I. Na, and D.H. Suh Red light phototherapy alone is effective for acne vulgaris: randomized, single-blinded clinical trial Dermatol Surg 33 2007 1228 1233
4. P. Papageorgiou, A. Katsambas, and A. Chu Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris Br J Dermatol 142 2000 973 978
5. V. Sigurdsson, A.C. Knulst, and H. van Weelden Phototherapy of acne vulgaris with visible light Dermatology 194 1997 256 260
6. J.S. Orringer, S. Kang, T. Hamilton, W. Schumacher, S. Cho, and C. Hammerberg Treatment of acne vulgaris with a pulsed dye laser: a randomized controlled trial JAMA 291 2004 2834 2839
7. J.Y. Jung, Y.S. Choi, M.Y. Yoon, S.U. Min, and D.H. Suh Comparison of a pulsed dye laser and a combined 585/1,064-nm laser in the treatment of acne vulgaris Dermatol Surg 35 2009 1181 1187
8. E.D. Seaton, A. Charakida, P.E. Mouser, I. Grace, R.M. Clement, and A.C. Chu Pulsed-dye laser treatment for inflammatory acne vulgaris: randomised controlled trial Lancet 362 2003 1347 1352
9. J.S. Orringer, S. Kang, L. Maier, T.M. Johnson, D.L. Sachs, and D.J. Karimipour A randomized, controlled, split-face clinical trial of 1320-nm Nd:YAG laser therapy in the treatment of acne vulgaris J Am Acad Dermatol 56 2007 432 438
10. A.S. Glaich, P.M. Friedman, M.H. Jih, and L.H. Goldberg Treatment of inflammatory facial acne vulgaris with combination 595-nm pulsed-dye laser with dynamic-cooling-device and 1,450-nm diode laser Lasers Surg Med 38 2006 177 180
11. D.J. Goldberg, and J. Whitworth Laser skin resurfacing with the Q-switched Nd:YAG laser Dermatol Surg 23 1997 903 906 discussion 906-7
12. C.C. Sumian, F.B. Pitre, B.E. Gauthier, M. Bouclier, and S.R. Mordon Laser skin resurfacing using a frequency doubled Nd:YAG laser after topical application of an exogenous chromophore Lasers Surg Med 25 1999 43 50
13. S.C. O'Brien, J.B. Lewis, and W.J. Cunliffe The Leeds revised acne grading system J Dermatol Treat 9 1998 215 220
14. M.A. Trelles, I. Allones, and R. Luna Facial rejuvenation with a nonablative 1320 nm Nd:YAG laser: a preliminary clinical and histologic evaluation Dermatol Surg 27 2001 111 116
15. P.M. Friedman, M.H. Jih, G.R. Skover, G.S. Payonk, A. Kimyai-Asadi, and R.G. Geronemus Treatment of atrophic facial acne scars with the 1064-nm Q-switched Nd:YAG laser: six-month follow-up study Arch Dermatol 140 2004 1337 1341
16. R. Keller, W. Belda Junior, N.Y. Valente, and C.J. Rodrigues Nonablative 1,064-nm Nd:YAG laser for treating atrophic facial acne scars: histologic and clinical analysis Dermatol Surg 33 2007 1470 1476
17. D.H. Lee, Y.S. Choi, S.U. Min, M.Y. Yoon, and D.H. Suh Comparison of a 585-nm pulsed dye laser and a 1064-nm Nd:YAG laser for the treatment of acne scars: a randomized split-face clinical study J Am Acad Dermatol 60 2009 801 807
18. S.U. Min, Y.S. Choi, D.H. Lee, M.Y. Yoon, and D.H. Suh Comparison of a long-pulse Nd:YAG laser and a combined 585/1,064-nm laser for the treatment of acne scars: a randomized split-face clinical study Dermatol Surg 35 2009 1720 1727
19. M. Alam, T.S. Hsu, J.S. Dover, D.A. Wrone, and K.A. Arndt Nonablative laser and light treatments: histology and tissue effects - a review Lasers Surg Med 33 2003 30 39
20. S. Kang, S. Cho, J.H. Chung, C. Hammerberg, G.J. Fisher, and J.J. Voorhees Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo Am J Pathol 166 2005 1691 1699
21. Y. Yamamoto, and R.B. Gaynor Role of the NF-kappaB pathway in the pathogenesis of human disease states Curr Mol Med 1 2001 287 296
22. D.L. Boone, E.G. Lee, S. Libby, P.J. Gibson, M. Chien, and F. Chan Recent advances in understanding NF-kappaB regulation Inflamm Bowel Dis 8 2002 201 212
23. P. Angel, and M. Karin Specific members of the Jun protein family regulate collagenase expression in response to various extracellular stimuli Matrix Suppl 1 1992 156 164
24. D.L. Crowe, K.J. Tsang, and B. Shemirani Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression Neoplasia 3 2001 27 32
25. H. Birkedal-Hansen, W.G. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, and A. DeCarlo Matrix metalloproteinases: a review Crit Rev Oral Biol Med 4 1993 197 250
26. J. Kim, M.T. Ochoa, S.R. Krutzik, O. Takeuchi, S. Uematsu, and A.J. Legaspi Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses J Immunol 169 2002 1535 1541